You are here: Industry Insights > acute pain

News List

Pharmaceutical News of the Week (July. 6th-July. 10th) | PharmaSources.com - Updates on R&D PharmaSources/Caicai
July 21, 2020
With the second week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 6 sections: approval, R&D, policies, transactions, listing and miscellany that happened during July 6-10.
FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids for Acute Pain Management FDA
February 11, 2022
The U.S. Food and Drug Administration took new steps aimed at fostering the development of non-addictive alternatives to opioids to manage acute pain and decreasing exposure to opioids and preventing new addiction.
Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain drugs
July 23, 2021
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has begun a Phase 2 proof-of-concept (POC) study in acute pain following bunionectomy surgery with the selective NaV1.8 inhibitor VX-548 .